Eog Res (EOG) Holder Kentucky Retirement Systems Has Decreased Its Position by $340,680 as Valuation Declined; As Amgen (AMGN) Valuation Declined, Sarasin & Partners Llp Lowered Holding by $24.85 Million

EOG Resources, Inc. (NYSE:EOG) Logo

Kentucky Retirement Systems decreased its stake in Eog Res Inc (EOG) by 8.3% based on its latest 2018Q3 regulatory filing with the SEC. Kentucky Retirement Systems sold 2,040 shares as the company’s stock declined 11.03% with the market. The institutional investor held 22,537 shares of the energy company at the end of 2018Q3, valued at $3.78 million, down from 24,577 at the end of the previous reported quarter. Kentucky Retirement Systems who had been investing in Eog Res Inc for a number of months, seems to be less bullish one the $56.18B market cap company. The stock decreased 2.27% or $2.25 during the last trading session, reaching $96.87. About 3.20M shares traded. EOG Resources, Inc. (NYSE:EOG) has risen 2.00% since January 11, 2018 and is uptrending. It has outperformed by 2.00% the S&P500.

Sarasin & Partners Llp decreased its stake in Amgen Inc (AMGN) by 12.3% based on its latest 2018Q3 regulatory filing with the SEC. Sarasin & Partners Llp sold 120,067 shares as the company’s stock declined 4.15% with the market. The institutional investor held 855,932 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $177.43 million, down from 975,999 at the end of the previous reported quarter. Sarasin & Partners Llp who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $127.80B market cap company. The stock decreased 1.05% or $2.12 during the last trading session, reaching $200.56. About 3.34 million shares traded or 8.68% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 11.57% since January 11, 2018 and is uptrending. It has outperformed by 11.57% the S&P500. Some Historical AMGN News: 21/04/2018 – DJ Amgen Inc, Inst Holders, 1Q 2018 (AMGN); 16/03/2018 – Biotechnology Companies with Great Potential; 05/04/2018 – Samsung, Biogen Reach Deal With AbbVie to Sell Near Copy of Humira; 23/05/2018 – Teva and Eli Lilly are in a race to put a second migraine drug on the market, after rival Amgen won FDA approval last week for Aimovig to prevent migraine headaches in adults; 24/04/2018 – AMGEN CHIEF FINL OFFICER DAVID MELINE SPEAKS ON CONF. CALL; 17/05/2018 – FDA: Grants Approval of Aimovig to Amgen Inc; 17/05/2018 – Novartis and Amgen Announce FDA Approval of Aimovig for Migraine Prevention; 21/05/2018 – AMGEN INC – APPROVAL OF PROLIA FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS IS BASED ON DATA FROM A PHASE 3 STUDY; 27/04/2018 – Amgen’s Prolia Gets Use Extension Recommendation (Correct); 25/05/2018 – Amgen Inc. | romiplostim | Nplate | 05/24/2018 | Treatment of patients acutely exposed to myelosuppressive doses of radiation following radiological/nuclear incident | Designated | NFDA | N/A | | N/A

Sarasin & Partners Llp, which manages about $17.00B and $5.31B US Long portfolio, upped its stake in Industrias Bachoco S A B De (NYSE:IBA) by 15,000 shares to 125,000 shares, valued at $6.78 million in 2018Q3, according to the filing. It also increased its holding in Lauder Estee Cos Inc (NYSE:EL) by 23,643 shares in the quarter, for a total of 42,312 shares, and has risen its stake in Middleby Corp (NASDAQ:MIDD).

Investors sentiment decreased to 0.87 in 2018 Q3. Its down 0.12, from 0.99 in 2018Q2. It is negative, as 49 investors sold AMGN shares while 550 reduced holdings. 130 funds opened positions while 393 raised stakes. 470.42 million shares or 2.68% less from 483.36 million shares in 2018Q2 were reported. 2,936 are owned by Somerville Kurt F. First City Management reported 3,820 shares. Greylin Mangement has invested 0.7% in Amgen Inc. (NASDAQ:AMGN). 175,024 are held by Fjarde Ap. Mountain Pacific Advisers Incorporated Id owns 3,011 shares or 0.06% of their US portfolio. Ls Advsrs Ltd Liability Co invested in 1.04% or 87,326 shares. 128,920 were reported by Berkshire Asset Ltd Liability Pa. Baldwin Brothers Ma holds 2.07% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 71,435 shares. Roundview Cap Ltd has invested 0.25% in Amgen Inc. (NASDAQ:AMGN). Northstar Group Inc Inc owns 2,465 shares or 0.23% of their US portfolio. Victory Mngmt has invested 0.01% in Amgen Inc. (NASDAQ:AMGN). Hsbc Public Limited Company holds 0.24% or 710,000 shares. Doheny Asset Ca accumulated 0.71% or 6,571 shares. The Tennessee-based Delta Asset Mngmt Tn has invested 0.05% in Amgen Inc. (NASDAQ:AMGN). Atria Invs Ltd has 0.15% invested in Amgen Inc. (NASDAQ:AMGN) for 18,346 shares.

Since November 29, 2018, it had 0 insider purchases, and 2 insider sales for $4.27 million activity. $360,520 worth of Amgen Inc. (NASDAQ:AMGN) was sold by Patton Cynthia M.

Among 27 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 16 Hold. Therefore 41% are positive. Amgen Inc. had 101 analyst reports since August 3, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Buy” rating in Wednesday, August 23 report. The company was maintained on Wednesday, June 7 by Bernstein. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by BMO Capital Markets on Friday, July 21. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Hold” rating by BMO Capital Markets on Friday, September 22. Oppenheimer maintained it with “Buy” rating and $18900 target in Monday, June 5 report. BMO Capital Markets maintained the shares of AMGN in report on Friday, February 2 with “Market Perform” rating. The stock has “Market Perform” rating by Raymond James on Tuesday, September 1. The stock has “Neutral” rating by JP Morgan on Wednesday, January 24. As per Wednesday, July 26, the company rating was maintained by UBS. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, December 15.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Fool.com which released: “Better Buy: Biogen vs. Amgen – The Motley Fool” on December 15, 2018, also Streetinsider.com with their article: “Amgen (AMGN), ECB Announce EVENITY Received Approval In Japan For Treatment of Osteoporosis – StreetInsider.com” published on January 08, 2019, Nasdaq.com published: “Health Care Sector Update for 12/13/2018: VBIV, AGTC, AMPE, JNJ, PFE, MRK, ABT, AMGN – Nasdaq” on December 13, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Nasdaq.com and their article: “The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte – Nasdaq” published on December 20, 2018 as well as Nasdaq.com‘s news article titled: “Amgen (AMGN) Stock Moves -1.52%: What You Should Know – Nasdaq” with publication date: January 03, 2019.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on February, 7. They expect $3.25 EPS, up 12.46% or $0.36 from last year’s $2.89 per share. AMGN’s profit will be $2.07 billion for 15.43 P/E if the $3.25 EPS becomes a reality. After $3.69 actual EPS reported by Amgen Inc. for the previous quarter, Wall Street now forecasts -11.92% negative EPS growth.

More important recent EOG Resources, Inc. (NYSE:EOG) news were published by: Fool.com which released: “3 Great Income Stocks That Could Double Their Dividends – The Motley Fool” on December 16, 2018, also 247Wallst.com published article titled: “Natural Gas Price Adds to Gains Following Inventory Report – 24/7 Wall St.”, Seekingalpha.com published: “Hartstreet: Lea County King Concho Dethrones EOG – Seeking Alpha” on December 12, 2018. More interesting news about EOG Resources, Inc. (NYSE:EOG) was released by: Fool.com and their article: “Why EOG Resources Stock Tumbled More Than 15% in December – Motley Fool” with publication date: January 07, 2019.

Since September 11, 2018, it had 0 insider purchases, and 3 sales for $818,191 activity. CRISP CHARLES R also sold $209,309 worth of EOG Resources, Inc. (NYSE:EOG) shares. WISNER FRANK G also sold $291,679 worth of EOG Resources, Inc. (NYSE:EOG) shares.

Among 42 analysts covering EOG Resources (NYSE:EOG), 33 have Buy rating, 0 Sell and 9 Hold. Therefore 79% are positive. EOG Resources had 156 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, February 3 by GMP Securities. As per Tuesday, January 30, the company rating was maintained by Jefferies. The firm has “Underperform” rating by CLSA given on Monday, August 10. The firm has “Sector Perform” rating by RBC Capital Markets given on Tuesday, November 8. The rating was downgraded by Bank of America on Thursday, January 4 to “Neutral”. Bernstein maintained EOG Resources, Inc. (NYSE:EOG) rating on Monday, May 16. Bernstein has “Outperform” rating and $93 target. The firm earned “Neutral” rating on Friday, May 4 by Bank of America. BMO Capital Markets maintained EOG Resources, Inc. (NYSE:EOG) rating on Tuesday, October 10. BMO Capital Markets has “Buy” rating and $105.0 target. On Friday, September 28 the stock rating was reinitiated by PiperJaffray with “Overweight”. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, September 1 report.

Kentucky Retirement Systems, which manages about $1.37B US Long portfolio, upped its stake in Schwab Charles Corp New (NYSE:SCHW) by 44,814 shares to 95,796 shares, valued at $2.49M in 2018Q3, according to the filing. It also increased its holding in Avalonbay Cmntys Inc (NYSE:AVB) by 4,175 shares in the quarter, for a total of 10,043 shares, and has risen its stake in Kroger Co (NYSE:KR).

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.